Robert F. Furchgott, from The AHA approves its first year Impact Goal for the nation: to reduce coronary heart disease, stroke and risk factors by 25 percent by The revised goals by were to. Get With The Guidelines launches to help healthcare providers consistently treat patients with proven standards and procedures by using quality improvement measures. In , the program had reached 1 million patients. AHA-funded researcher Dr.
Christine S. Moravec reports that mechanical pumps, called left ventricular assist devices, can reverse diminished heart muscle performance in people with heart failure who are awaiting transplantation. The FDA approves the first drug-coated stent to keep blocked arteries open while also releasing medications. Andrew R. Marks, a researcher funded by the AHA, developed drug-coated stents to prevent the tiny wire tubes from accumulating fatty plaques.
Peter Agre is awarded the Nobel Prize in Chemistry for his discovery of aquaporins, proteins that govern the movement of water in and out of cells. This discovery leads to new research examining brain swelling after a stroke and water retention in heart failure.
Offices in Belgium, Hong Kong and Dubai follow. Go Red For Women launches. National Wear Red Day becomes a way for people to raise awareness about heart disease. Its outreach later includes Hispanic women, who face an even higher risk of heart disease. Clinton Foundation establish the Alliance for a Healthier Generation to fight the childhood obesity epidemic by engaging with industry leaders, educators, parents, healthcare professionals and kids.
The program also helps people take action to prevent stroke. Funding from the Association enables Dr. Stephen Young to identify a new molecule that may help regulate the delivery of fats to cells for energy and storage. The finding could lead to a better understanding of how we use fats from the foods we eat. Mario Capecchi receives the Nobel Prize in Physiology or Medicine for his discoveries in gene targeting. Gene targeting is used in research for heart disease, high blood pressure, cancer and other conditions.
Mission: Lifeline launches to improve emergency systems of care for people who suffer from severe heart attacks that require urgent care known as STEMIs. The focus is on the results of healthcare interventions for people who have or are at risk for heart disease and stroke. Gordon Ewy accumulated evidence from multiple studies dating to the s that show uninterrupted, high-quality chest compressions — without mouth-to-mouth respiration — keep blood circulating to vital organs.
As a result, the AHA releases new recommendations in that bystanders can skip mouth-to-mouth and use Hands-Only CPR to help an adult who collapses suddenly. AHA launches six spinoffs of the Journal Circulation to provide scientifically specialized information. No society has ever done that in a single calendar year. The journals are:. Circulation: Arrhythmia and Electrophysiology. Circulation: Cardiovascular Imaging. Circulation: Cardiovascular Interventions.
Circulation: Cardiovascular Quality and Outcomes. Martin Chalfie wins the Nobel Prize in Chemistry for developing green fluorescent protein as a genetic tag to see inside living cells, including heart cells, to better understand how the cells are made and work.
This fellowship gave U. The centers conduct studies to determine how regeneration of those cells can help improve outcomes for heart attack and heart failure patients.
The law lets the FDA regulate tobacco, bans candy-flavored cigarettes and adds large warning labels to tobacco products. Billboard advertising near schools is banned, and tobacco companies can no longer alter products to make them more addictive or make misleading health claims. The AHA announces a major goal to improve the cardiovascular health of all Americans by 20 percent while reducing deaths from cardiovascular diseases and stroke by 20 percent by Ralph Steinman receives the Nobel Prize in Physiology or Medicine for his discovery of dendritic cells and their role in adaptive immunology.
The cells help curb infections and develop immunologic memory for protection in the future. His insights have been critical in the field transplantation. Iowa and Alabama are the first two states to require it.
By , 37 states pass such legislation, meaning 2. Robert Lefkowitz is co-recipient of the Nobel Prize in Chemistry for studies of G-protein-coupled receptors. These allow cells to sense and respond to internal and external signals, such as flavors, odor, light and danger.
Such studies have been instrumental in developing more effective drugs to treat cardiovascular disease and other illnesses. The Cardiovascular Genome-Phenome Study launches to accelerate groundbreaking research into personalized medicine. This leads to the formation of the AHA Tobacco Regulation and Addiction Center A-TRAC , constituted by the American Heart Association AHA and eight leading academic institutions to aid the development and evaluation of tobacco product regulation by the FDA and thereby contribute to the protection of public health and reduction of tobacco-related disease, disability and death.
The AHA is the leading non-profit funder of heart disease and stroke research outside the federal government. Circulation: Cardiovascular Genetics updated its name to Circulation: Genomic and Precision Medicine to reflect the evolution of science in this discipline. The journal publishes articles related to research in human cardiovascular genetics, genomics, and systems biology.
Our last two ventures were acquired by well-known public companies. We knew that people were struggling to set clear business strategy and connect it to the work of building products that customers love.
There was an opportunity to take everything we had learned and build a product that would help people set goals and initiatives and connect them to the execution. And it would help them better collaborate and provide greater organizational transparency into who was working on what.
We wanted to do something different, something true. We did not want to build just another software company. We wanted to build an exceptionally high-quality product and create a place where people would love to work.
And we wanted to allow people to work from where they were happiest — we are still a percent distributed company today. We were well acquainted with the startup model that had been celebrated in Silicon Valley since the mids, and we knew there had to be a better way to fund our vision than chasing venture capital and trying to manufacture scale with no substance.
We self-funded the business and aimed to be profitable fast. It was immediately obvious that others shared our vision. Product managers and company builders were looking for a better way to build what their customers want and enjoy their own work at the same time.
We thoughtfully crafted the first version of Aha! During the early access program, we spoke with and demonstrated the software to more than product development teams.
We ended the beta program in the fall of and signed up paying enterprise customers within four months. We were profitable and on our way. As Aha! It is the engine driving our successful interactions with customers, the engine driving our success. TRM is centered around the belief that interactions with urgency propel people and organizations forward. It is a simple way to have mutually beneficial exchanges.
In October , we were fortunate to be able to acquire the most important one-word domain for product managers. We wanted to provide product managers, entrepreneurs, and founders with a dedicated space to connect and learn from one another. So we launched and sponsored Roadmap. Arthur S. Robert B. The day-to-day operations of the Association are led by the executive director.
Corey Prize Raymond J. Cunningham Prize John H. Klein Prize Waldo G. Marraro Prize George L. Mosse Prize John E. Palmegiano Prize James A. Schmitt Grant J. Beveridge Award Recipients Albert J. Corey Prize Recipients Raymond J. Cunningham Prize Recipients John H. Fagg Prize Recipients John K. Franklin Jameson Award Recipients J.
0コメント